Spark Therapeutics, Inc.
Get Full AccessDescription
- At Spark Therapeutics, we dont follow footsteps. We create the path. We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our mission is seemingly impossible to others, but not to us: Challenge the inevitability of genetic disease by discovering, developing and delivering treatments in ways unimaginable until now. Over the past three years, we have doubled in size every year, bringing in a wide range of expertise to build a fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver. We are seeking talented individuals with diverse experiences, abilities and interests who have the curiosity, courage and drive to reimagine a new health care paradigm. Join us on a journey through uncharted territory seeking to bring gene therapy for genetic diseases to people worldwide. Our validated scientific and technology platform has delivered proof-of-concept data in the retina and liver. Our most advanced investigational candidate, voretigene neparvovec, for the treatment of biallelic RPE65-mediated IRD, has received orphan designations in the U.S. and the EU, and breakthrough therapy designation in the U.S. The pipeline also includes SPK-7001, in a Phase 1/2 trial for choroideremia; SPK-9001 (which also has received both breakthrough therapy and orphan product designations) in a Phase 1/2 trial for hemophilia B being developed in collaboration with Pfizer; and SPK-8011, in a Phase 1/2 trial for hemophilia A to which Spark Therapeutics retains global commercialization rights. Know that working at Spark Therapeutics is not just another job; it is a once-in-a-lifetime opportunity. We embrace the challenges before us and the uncertainty inherent in them. Ultimately, we are working to create a world free of genetic disease. To learn more, visit www.sparktx.com.
-
Headquarters:3737 Market Street Suite 1300, Philadelphia, Pennsylvania, United States
More -
Phone Number: +1 888-772-7560
-
Website: https://www.sparktx.com
-
Employees:583
-
Revenue:$500M - 1B
-
Legal Name:Spark Therapeutics, Inc.
-
Spark Therapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 621511 |
Show More
Frequently Asked Questions regarding Spark Therapeutics, Inc.
-
Where are Spark Therapeutics, Inc.'s Headquarters?
Spark Therapeutics, Inc.'s Headquarters are in 3737 Market Street Suite 1300,Philadelphia,Pennsylvania,United States
-
What is Spark Therapeutics, Inc.'s phone number?
Spark Therapeutics, Inc.'s phone number is +1 888-772-7560
-
What is Spark Therapeutics, Inc.'s official website?
Spark Therapeutics, Inc.'s official website is https://www.sparktx.com
-
What is Spark Therapeutics, Inc.'s Revenue?
Spark Therapeutics, Inc.'s revenue is $500M - 1B
-
What is Spark Therapeutics, Inc.'s NAICS code?
Spark Therapeutics, Inc.'s NAICS code is 621511
-
How many employees are working in Spark Therapeutics, Inc.
Spark Therapeutics, Inc. has 583 employees
-
What is Spark Therapeutics, Inc.'s Industry?
Spark Therapeutics, Inc. is in the industry of Biotechnology
-
Who is Spark Therapeutics, Inc.'s CEO?
Spark Therapeutics, Inc.'s CEO is Jeffrey Marrazzo

